Showing results (211-220 of 241) with videos related to
Sort By:
Pageof 25
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 2, 2025
Effective long-term prophylaxis with lanadelumab in adolescents with hereditary angioedema: EMPOWER/ENABLERaffi Tachdjian, Aleena Banerji, Paula J Busse, et al.British Journal of Anaesthesia|February 29, 2024
Behavioural disorders after prenatal exposure to anaesthesia for maternal surgeryCaleb Ing, Jeffrey H Silber, Deven Lackraj, et al.Annals of Surgery|September 15, 2020
Urgent Care Centers Delay Emergent Surgical Care Based on Patient Insurance Status in The United StatesWalter R Hsiang, Daniel Wiznia, Laurie Yousman, et al.Journal of General Internal Medicine|December 12, 2023
Mortality Among Older Medical Patients at Flagship Hospitals and Their AffiliatesSiddharth Jain, Paul R Rosenbaum, Joseph G Reiter, et al.Journal of General Internal Medicine|November 17, 2022
Defining Multimorbidity in Older Patients Hospitalized with Medical ConditionsSiddharth Jain, Paul R Rosenbaum, Joseph G Reiter, et al.AIDS Research and Therapy|November 4, 2011
The antiretroviral efficacy of highly active antiretroviral therapy and plasma nevirapine concentrations in HIV-TB co-infected Indian patients receiving rifampicin based antituberculosis treatmentSanjeev Sinha, Sahajal Dhooria, Sanjiv Kumar, et al.BMC Infectious Diseases|October 19, 2013
Nevirapine versus efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and tuberculosis infections in India: a pilot studySanjeev Sinha, Puroshottam Raghunandan, Rahul Chandrashekhar, et al.Rheumatology International|October 18, 2021
Clinical presentation and treatment outcomes of arterial involvement in Behçet's disease: a single-centre experienceArghya Chattopadhyay, Siddharth Jain, G S R S N K Naidu, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 14, 2015
Intermittent Directly Observed Therapy for Abdominal Tuberculosis: A Multicenter Randomized Controlled Trial Comparing 6 Months Versus 9 Months of TherapyGovind K Makharia, Uday C Ghoshal, Balakrishnan S Ramakrishna, et al.European Journal of Clinical Investigation|November 6, 2025
Long-term effectiveness and safety outcomes in adults with Fabry disease treated with agalsidase alfa: 20 years of data from the Fabry Outcome SurveyDerralynn A Hughes, Guillem Pintos-Morell, Christoph Kampmann, et al.Pageof 25